Arena Pharmaceuticals, Inc.
San Diego, California, United States
Pharmaceutical company in San Diego, California
6154 Nancy Ridge Dr, San Diego, CA 92121
About Arena Pharmaceuticals, Inc.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Arena Pharmaceuticals, Inc.
During the past decade, Arena Pharmaceuticals, Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis
2005-04-08
2009-09-07
Completed
829
Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPD
2002-07-01
2003-03-01
Completed
141
Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBV
2003-07-01
2004-12-01
Terminated
80
Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBV
2003-06-01
2004-11-01
Terminated
180
Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia
2006-04-01
2007-08-01
Completed
1,695
A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer
2006-06-01
2013-10-01
Completed
372
Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials
2004-06-01
2006-03-01
Terminated
Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial
2005-06-01
Completed
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Arena Pharmaceuticals, Inc.
According to Clinical.Site data, the most researched conditions in "Arena Pharmaceuticals, Inc." are
"Obesity" (3 trials) and "Primary Insomnia" (1 trials). Many other conditions were trialed in "Arena Pharmaceuticals, Inc." in a lesser frequency.
Clinical Trials Intervention Types at Arena Pharmaceuticals, Inc.
Most popular intervention types in "Arena Pharmaceuticals, Inc." are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Lorcaserin 10 mg once daily (QD)" (2 trials), "Lorcaserin 10 mg twice a day (BID)" (2 trials), "Matching Placebo" (2 trials), "APD125" (1 trials) and "Lorcaserin 10 mg BID" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Arena Pharmaceuticals, Inc.
The vast majority of trials in "Arena Pharmaceuticals, Inc." are
4 trials for "All" genders.
Clinical Trials Status at Arena Pharmaceuticals, Inc.
Currently, there are NaN active trials in "Arena Pharmaceuticals, Inc.".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Arena Pharmaceuticals, Inc.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Arena Pharmaceuticals, Inc., 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".